This site requires JavaScript to be enabled to work properly. Please modify your settings or use a different browser to continue

You are now leaving GSK’s website

This link will take you to a non-GSK website. GSK does not recommend, endorse or accept liability for sites controlled by third-parties.


Go back

Contact update

From 1st February 2021 we will be reducing our telephone line support service and from 1st April 2021, we will be contactable via email and click to chat services only. This does not include our Medical or Safety teams who will remain contactable via telephone on 0800 221 441. If your query is regarding supply of GSK products, please contact your wholesaler

Chat to us now

If you are unable to find the answer to your query on the FAQ page, connect with one of our agents

Live Chat

Report an adverse event

Adverse events should be reported to the Medicines and Healthcare Products Regulatory Agency (MHRA). Reporting forms and information can be found at:

Adverse events should also be reported to GSK on 0800 221 441, or via the Report an adverse event form.

Request a contact

Please click on the link below and fill in the enquiry form in order to be contacted by a suitable GSK contact.

Request a contact

Please note that any personal information shared with GSK using our enquiry form will only be used to respond to your enquiry.

Stay informed by email

Sign up to receive emails from GSK (may contain promotional information).

Register now

Call us

For general enquiries, call us on one of the numbers below.

Customer Contact Centre: +44 (0)800 221 441

UK Consumer Healthcare +44 (0)800 783 8881

Corporate Switchboard: +44 (0)20 8047 5000

GSK recognises that there may be circumstances when it is appropriate for healthcare professionals to give their patients investigational medicines to treat life threatening or seriously debilitating diseases/conditions where no satisfactory alternatives exist. Read our public policy for compassionate use.

GSK may monitor our technology tools and services (including email, phone, and other communications sent to and from GSK) to maintain the security of systems, and to protect our staff, customers and business partners from cyber threats and loss of information. Examples of these monitoring activities include checks for offensive materials, viruses and other malignant code, and unauthorized or unlawful activity.

You can learn about the information that we may process about you, and how we use your information by reading our Privacy policy.